Cell-Based Medicine

Oct 23, 2024 | cell.com | Biomedical Engineering |Kris M. White |Cell-Based Medicine |Harwell Science

1Center of Protein Engineering and Therapeutics, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 2Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK 3Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 4Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 5Biomedical Engineering and...

Oct 11, 2024 | cell.com | Blood Disorders |Cell-Based Medicine

KeywordsmicrogliamacrophageTAMmonocytehigh-grade gliomapediatric gliomadiffuse midline gliomadisease-associated macrophageCCR5CCR1Get full text accessLog in, subscribe or purchase for full access. References1. Mackay, A. ∙ Burford, A. ∙ Carvalho, D. ... Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine GliomaCancer Cell. 2017; 32:520-537.e52. Juratli, T.A. ∙ Qin, N. ∙ Cahill, D.P. ...

Sep 3, 2024 | europeanurology.com | Sujit Nair |Hassan Muhammad |Rachel Brody |Cell-Based Medicine

Get full text accessLog in, subscribe or purchase for full access. ReferencesKane, C.J. ∙ Eggener, S.E. ∙ Shindel, A.W. ... Variability in outcomes for patients with intermediate-risk prostate cancer (Gleason score 7, International Society of Urological Pathology Gleason group 2–3) and implications for risk stratification: a systematic reviewEur Urol Focus. 2017; 3:487-497Kurbegovic, S. ∙ Drimer Berg, K. ∙ Birkebæk Thomsen, F. ...

Feb 5, 2024 | molecularneurodegeneration.biomedcentral.com | Bertrand Russell |Cell-Based Medicine

The sample included 364 deceased individuals who donated their brain to the Understanding Neurological Injury and Traumatic Encephalopathy (UNITE) brain bank as part of the UNITE research study [10]. The sample included only brain donors neuropathologically diagnosed with CTE. Most brain donations to the UNITE study originated with the next-of-kin contacting the brain bank near the time of death.

May 3, 2023 | actaneurocomms.biomedcentral.com | Cell-Based Medicine

SamplesA cohort of 100 glioma cases diagnosed from 2019 to 2022 at the Mount Sinai Health System (MSHS) were selected for the study, and were used under approved institutional review board protocol. The combined histopathologic / molecular integrated diagnosis was based on guidelines from the 5th edition (2021) of the WHO classification of CNS tumors [1].